Number of Founded Organizations 1
CB Rank (Person) 1,256,635

Extensive experience and expertise in the pharmaceutical and biotechnology industries, particularly in oncology. Prior to ACT, Dr. Sherman was Director of Clinical Research and Director of Scientific Affairs for YM Biosciences Inc., where he was responsible for preclinical and clinical development, as well as registration strategies for all

oncology and pain products in YM Biosciences’ portfolio.Dr. Sherman was also Scientific Director of Oncology for AstraZeneca Canada Inc.

Number of Current Jobs 1
Igor Sherman is the President and CEO at Alpha Cancer Technologies.
There is no recent news or activity for this profile.